Himatsingka Seide Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 30, 2025, 10:36 am

Quick Insight

Himatsingka Seide Ltd, a player in the Textiles – Synthetic/Silk industry, currently trades at a price of 119 with a market cap of ₹1,499 Cr. The company's P/E stands at 9.96, ROE at 7.78%, and ROCE at 9.45%. With an OPM of 18% and a net profit of ₹76 Cr, it faces challenges with high borrowings of ₹2,567 Cr and a CCC of 184 days. Additionally, the P/BV ratio is low at 0.77x, indicating potential undervaluation. Investors should closely monitor the company's debt levels and operational efficiency to gauge future performance and mitigate risks.

Competitors of Himatsingka Seide Ltd

All Competitor Stocks of Himatsingka Seide Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:40 am

Below is a detailed analysis of the quarterly data for Himatsingka Seide Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 657.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 657.00 Cr..
• For Expenses, as of Jun 2025, the value is 536.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 539.00 Cr. (Mar 2025) to 536.00 Cr., marking a decrease of 3.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 121.00 Cr.. The value appears strong and on an upward trend. It has increased from 118.00 Cr. (Mar 2025) to 121.00 Cr., marking an increase of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00%.
• For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from -70.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 74.00 Cr..
• For Interest, as of Jun 2025, the value is 72.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 75.00 Cr. (Mar 2025) to 72.00 Cr., marking a decrease of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 38.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from -64.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 78.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from -119.00% (Mar 2025) to 25.00%, marking an increase of 144.00%.
• For Net Profit, as of Jun 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.87. The value appears to be declining and may need further review. It has decreased from 0.95 (Mar 2025) to 0.87, marking a decrease of 0.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:19 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:01 pm

Below is a detailed analysis of the balance sheet data for Himatsingka Seide Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Mar 2024) to 63.00 Cr., marking an increase of 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,970.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,510.00 Cr. (Mar 2024) to 1,970.00 Cr., marking an increase of 460.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,567.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 2,898.00 Cr. (Mar 2024) to 2,567.00 Cr., marking a decrease of 331.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,060.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,321.00 Cr. (Mar 2024) to 1,060.00 Cr., marking a decrease of 261.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 5,660.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,777.00 Cr. (Mar 2024) to 5,660.00 Cr., marking a decrease of 117.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2,518.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,947.00 Cr. (Mar 2024) to 2,518.00 Cr., marking a decrease of 429.00 Cr..
• For CWIP, as of Mar 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 32.00 Cr. (Mar 2024) to 13.00 Cr., marking a decrease of 19.00 Cr..
• For Investments, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 9.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,117.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,796.00 Cr. (Mar 2024) to 3,117.00 Cr., marking an increase of 321.00 Cr..
• For Total Assets, as of Mar 2025, the value is 5,660.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,777.00 Cr. (Mar 2024) to 5,660.00 Cr., marking a decrease of 117.00 Cr..

However, the Borrowings (2,567.00 Cr.) are higher than the Reserves (1,970.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Himatsingka Seide Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 11.46. This value is within the healthy range. It has increased from -6.51 (Mar 23) to 11.46, marking an increase of 17.97.
• For Diluted EPS (Rs.), as of Mar 24, the value is 11.03. This value is within the healthy range. It has increased from -6.51 (Mar 23) to 11.03, marking an increase of 17.54.
• For Cash EPS (Rs.), as of Mar 24, the value is 27.52. This value is within the healthy range. It has increased from 10.15 (Mar 23) to 27.52, marking an increase of 17.37.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 158.34. It has increased from 147.17 (Mar 23) to 158.34, marking an increase of 11.17.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 158.34. It has increased from 147.17 (Mar 23) to 158.34, marking an increase of 11.17.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 288.60. It has increased from 271.97 (Mar 23) to 288.60, marking an increase of 16.63.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 62.70. This value is within the healthy range. It has increased from 35.15 (Mar 23) to 62.70, marking an increase of 27.55.
• For PBIT / Share (Rs.), as of Mar 24, the value is 46.64. This value is within the healthy range. It has increased from 18.49 (Mar 23) to 46.64, marking an increase of 28.15.
• For PBT / Share (Rs.), as of Mar 24, the value is 16.53. This value is within the healthy range. It has increased from -7.64 (Mar 23) to 16.53, marking an increase of 24.17.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 11.46. This value is within the healthy range. It has increased from -6.51 (Mar 23) to 11.46, marking an increase of 17.97.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 11.46. This value is within the healthy range. It has increased from -6.51 (Mar 23) to 11.46, marking an increase of 17.97.
• For PBDIT Margin (%), as of Mar 24, the value is 21.72. This value is within the healthy range. It has increased from 12.92 (Mar 23) to 21.72, marking an increase of 8.80.
• For PBIT Margin (%), as of Mar 24, the value is 16.16. This value is within the healthy range. It has increased from 6.79 (Mar 23) to 16.16, marking an increase of 9.37.
• For PBT Margin (%), as of Mar 24, the value is 5.72. This value is below the healthy minimum of 10. It has increased from -2.80 (Mar 23) to 5.72, marking an increase of 8.52.
• For Net Profit Margin (%), as of Mar 24, the value is 3.97. This value is below the healthy minimum of 5. It has increased from -2.39 (Mar 23) to 3.97, marking an increase of 6.36.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.97. This value is below the healthy minimum of 8. It has increased from -2.39 (Mar 23) to 3.97, marking an increase of 6.36.
• For Return on Networth / Equity (%), as of Mar 24, the value is 7.23. This value is below the healthy minimum of 15. It has increased from -4.42 (Mar 23) to 7.23, marking an increase of 11.65.
• For Return on Capital Employeed (%), as of Mar 24, the value is 12.78. This value is within the healthy range. It has increased from 5.39 (Mar 23) to 12.78, marking an increase of 7.39.
• For Return On Assets (%), as of Mar 24, the value is 1.94. This value is below the healthy minimum of 5. It has increased from -1.15 (Mar 23) to 1.94, marking an increase of 3.09.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 1.02. This value exceeds the healthy maximum of 1. There is no change compared to the previous period (Mar 23) which recorded 1.02.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.79. This value exceeds the healthy maximum of 1. It has decreased from 1.86 (Mar 23) to 1.79, marking a decrease of 0.07.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.50. It has increased from 0.47 (Mar 23) to 0.50, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 24, the value is 1.24. This value is below the healthy minimum of 1.5. It has increased from 1.07 (Mar 23) to 1.24, marking an increase of 0.17.
• For Quick Ratio (X), as of Mar 24, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 23) to 0.79, marking an increase of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.40. This value is below the healthy minimum of 4. It has increased from 1.27 (Mar 23) to 1.40, marking an increase of 0.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -7.68 (Mar 23) to 0.00, marking an increase of 7.68.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.92 (Mar 23) to 0.00, marking a decrease of 4.92.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 107.68 (Mar 23) to 0.00, marking a decrease of 107.68.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.08 (Mar 23) to 0.00, marking a decrease of 95.08.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 2.08. This value is below the healthy minimum of 3. It has increased from 1.35 (Mar 23) to 2.08, marking an increase of 0.73.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 23) to 1.38, marking an increase of 0.63.
• For Enterprise Value (Cr.), as of Mar 24, the value is 3,836.86. It has increased from 3,264.89 (Mar 23) to 3,836.86, marking an increase of 571.97.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.35. This value is within the healthy range. It has increased from 1.22 (Mar 23) to 1.35, marking an increase of 0.13.
• For EV / EBITDA (X), as of Mar 24, the value is 6.22. This value is within the healthy range. It has decreased from 9.44 (Mar 23) to 6.22, marking a decrease of 3.22.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.42. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 23) to 0.42, marking an increase of 0.17.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 107.68 (Mar 23) to 0.00, marking a decrease of 107.68.
• For Price / BV (X), as of Mar 24, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.46 (Mar 23) to 0.77, marking an increase of 0.31.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.42. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 23) to 0.42, marking an increase of 0.17.
• For EarningsYield, as of Mar 24, the value is 0.09. This value is below the healthy minimum of 5. It has increased from -0.09 (Mar 23) to 0.09, marking an increase of 0.18.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness